Analyze ALKS

ShareShare on WhatsApp Share on Facebook Share on X

Equity Research · Deep diveIT-2026-ALKS · 2026-07-30

Alkermes plc (ALKS)

HealthcareDrug Manufacturers - Specialty & GenericNasdaqGSMarket cap $8.11B

$48.34

-4.28%

Analyst-style PDF, emailed within minutes

65/100

Positive bias

Automated weighted score · not a recommendation

Price source: Yahoo · live price · as of 23:00 · Data: Yahoo · SEC EDGAR · FINRA · Wikidata

About the company

Market cap

$8.11B

P/E

134.28

Beta

0.29

Employees

2.05K

Sector: HealthcareIndustry: Drug Manufacturers - Specialty & GenericExchange: NasdaqGSCountry: Ireland Website

What the company does

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Day range

$47.66$50.72

52-week range

$25.17$55.67

Price alert on ALKS

Get an in-app and mobile alert every time ALKS crosses a price you set.

Loading short data…

ALKS · Chart

Loading chart…

SMA20 SMA50 SMA200

Charts by TradingView

Support & resistance

Key trading levels, by timeframe

Day

Swing

Computing levels…

The technical signal compass

Sign up free and build your own trading bot with full backtesting. Live bots, real-time alerts and the bot gallery — with a Pro subscription.

Free sign-up

Alkermes plc (ALKS) is trading around $48.34 (-4.28% on the last session). Its 52-week range runs from $25.17 to $55.67. Technically: 7 buy signals, 4 sell and 1 neutral. It belongs to the Healthcare sector (Drug Manufacturers - Specialty & Generic), with a P/E of 134.3 and a 8B$ market cap. Data sourced from Yahoo · live price as of 23:00. This is data analysis only, not advice or a recommendation.

ALKS stock FAQ

What is ALKS's current price?

ALKS is trading around $48.34 (-4.28%), as of 23:00 per Yahoo · live price.

What is ALKS's 52-week price range?

Over the last 52 weeks ALKS ranged between a $25.17 low and a $55.67 high.

Which sector does ALKS belong to?

ALKS belongs to the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.

Disclosure & disclaimer: All information, scores, signals and trade plans on this site are produced by an automated algorithmic system and are based on technical and quantitative data only. They do not constitute investment advice, investment marketing or a recommendation to act, and are not a substitute for personal advice from a licensed professional that accounts for your needs and circumstances. We are not investment advisors. Trading securities involves substantial risk, up to the loss of your entire investment; every decision and action is your sole responsibility. i-trade and its operators bear no liability for any direct or indirect damage arising from reliance on this information.

0 買買 0 $ ▼ ↑ 0 % ₿ ₿ % 0 ↑ ▼ $ 0 買買 0 $ ▼# € € # ◇ 1 ▲ ↓ 売 1 1 売 ↓ ▲ 1 ◇ # € € # ◇ 1買 0 0 買 ↑ % 0 ▼ ₿ $ $ ₿ ▼ 0 % ↑ 買 0 0 買 ↑ %€ ↓ ↓ € ▲ 売 # 1 1 ◇ ◇ 1 1 # 売 ▲ € ↓ ↓ € ▲ 売0 ▼ ▼ 0 0 ₿ 買 % $ ↑ ↑ $ % 買 ₿ 0 0 ▼ ▼ 0 0 ₿↓ 1 1 ↓ # 1 € 売 ◇ ▲ ▲ ◇ 売 € 1 # ↓ 1 1 ↓ # 1▼ % % ▼ 買 $ 0 ₿ ↑ 0 0 ↑ ₿ 0 $ 買 ▼ % % ▼ 買 $1 売売 1 € ◇ ↓ 1 ▲ # # ▲ 1 ↓ ◇ € 1 売売 1 € ◇% ₿ ₿ % 0 ↑ ▼ $ 0 買買 0 $ ▼ ↑ 0 % ₿ ₿ % 0 ↑売 1 1 売 ↓ ▲ 1 ◇ # € € # ◇ 1 ▲ ↓ 売 1 1 売 ↓ ▲₿ $ $ ₿ ▼ 0 % ↑ 買 0 0 買 ↑ % 0 ▼ ₿ $ $ ₿ ▼ 01 ◇ ◇ 1 1 # 売 ▲ € ↓ ↓ € ▲ 売 # 1 1 ◇ ◇ 1 1 #$ ↑ ↑ $ % 買 ₿ 0 0 ▼ ▼ 0 0 ₿ 買 % $ ↑ ↑ $ % 買◇ ▲ ▲ ◇ 売 € 1 # ↓ 1 1 ↓ # 1 € 売 ◇ ▲ ▲ ◇ 売 €↑ 0 0 ↑ ₿ 0 $ 買 ▼ % % ▼ 買 $ 0 ₿ ↑ 0 0 ↑ ₿ 0▲ # # ▲ 1 ↓ ◇ € 1 売売 1 € ◇ ↓ 1 ▲ # # ▲ 1 ↓0 買買 0 $ ▼ ↑ 0 % ₿ ₿ % 0 ↑ ▼ $ 0 買買 0 $ ▼# € € # ◇ 1 ▲ ↓ 売 1 1 売 ↓ ▲ 1 ◇ # € € # ◇ 1

Building the strategy

ALKS stock FAQ

What is ALKS's current price?

ALKS is trading around $48.34 (-4.28%), as of 23:00 per Yahoo · live price.

What is ALKS's 52-week price range?

Over the last 52 weeks ALKS ranged between a $25.17 low and a $55.67 high.

Which sector does ALKS belong to?

ALKS belongs to the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.

Analyze ALKS

Alkermes plc (ALKS)

About the company

ALKS · Chart

Support & resistance

The technical signal compass

ALKS stock FAQ

Alkermes plc (ALKS)

About the company

ALKS · Chart

Support & resistance

The technical signal compass

ALKS stock FAQ

Income statement analysis

Institutional & insider data

Full analyst coverage